Echelard Yann 4
4 · TG THERAPEUTICS, INC. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
Echelard Yann
Director
Transactions
- Sale
Common Stock
2025-06-13$36.94/sh−10,000$369,400→ 228,816 total - Award
Common Stock
2025-06-12+14,718→ 238,816 total
Footnotes (4)
- [F1]Reflects a grant of restricted shares that will vest on June 12, 2026.
- [F2]Includes shares of restricted Common Stock, which vest over various time periods.
- [F3]These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations.
- [F4]Includes a weighted average price for shares sold in multiple transactions at prices ranging from $36.93 through $36.96, inclusive. Mr. Echelard undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.